Literature DB >> 26369257

NUCB2 gene polymorphism and its relationship with nesfatin-1 levels in polycystic ovary syndrome.

Mine Islimye Taskin1, Betul Eser2, Ertan Adali1, Hayrettin Kara3, Coskun Cuce4, Adnan Adil Hismiogulları3.   

Abstract

Nesfatin-1, encoded by the nucleobindin-2 (NUCB2) gene, is an anorexigenic protein related to energy metabolism, obesity, and insulin resistance. The aim of this study was to evaluate NUCB2 gene polymorphism (rs757081) and its association with serum levels of nesfatin-1 in obese and non-obese women with polycystic ovary syndrome (PCOS). In the study population, we analyzed 60 patients with PCOS and 26 age-matched healthy women as controls. The patients with PCOS were divided into two groups based on body mass index (BMI): obese group (n = 28) or non-obese group (n = 32). NUCB2 was genotyped using the polymerase chain reaction-restriction (PCR) technique. Serum nesfatin-1 level was measured by enzyme-linked immunosorbent assay (ELISA). Nesfatin-1 levels in the obese PCOS group were significantly lower than those in the non-obese PCOS and control groups (p < 0.001). There was no statistically significant difference in the distribution of NUCB2 genotypes among the groups (p > 0.05), whereas nesfatin-1 levels in the CC and CG genotypes were lower than those in the GG genotype. Nesfatin-1 decreases in PCOS, especially in obese women, and is negatively correlated with cardiometabolic risk factors. Although genotype disturbances of NUCB2 were similar among the groups, CC and CG genotypes accompanied lower nesfatin-1 levels. C allele of NUCB2 gene polymorphism and nesfatin-1 may play a role in the pathophysiology of PCOS.

Entities:  

Keywords:  Gene polymorphism; NUCB2; PCOS; nesfatin-1

Mesh:

Substances:

Year:  2015        PMID: 26369257     DOI: 10.3109/09513590.2015.1081682

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  4 in total

Review 1.  Review of Novel Potential Insulin Resistance Biomarkers in PCOS Patients-The Debate Is Still Open.

Authors:  Jagoda Kruszewska; Hanna Laudy-Wiaderny; Michał Kunicki
Journal:  Int J Environ Res Public Health       Date:  2022-02-13       Impact factor: 3.390

Review 2.  Association between rs1800795 polymorphism in the interleukin-6 gene and the risk of polycystic ovary syndrome: A meta-analysis.

Authors:  Linjie Chen; Zhifen Zhang; Jian Huang; Minjuan Jin
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

3.  Anorexigenic peptide (leptin, obestatin, nesfatin-1) levels and their impact on assisted reproductive technology treatment outcomes in patients with polycystic ovary syndrome.

Authors:  Bulut Varlı; Yavuz Emre Şükür; Batuhan Özmen; Berrin İmge Ergüder; Murat Sönmezer; Bülent Berker; Cem Atabekoğlu; Ruşen Aytaç
Journal:  Clin Exp Reprod Med       Date:  2021-11-30

4.  Association of Plasma IL-32 Levels and Gene Polymorphisms with Systemic Lupus Erythematosus in Chinese Han Population.

Authors:  Yanyun Wang; Bin Zhou; Yi Zhao; Xiuzhang Yu; Yi Liu; Lin Zhang
Journal:  Dis Markers       Date:  2016-02-29       Impact factor: 3.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.